10-27413327-GC-GCC

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP6_ModerateBA1

The ENST00000642324.1(PTCHD3):​c.923dupG​(p.Ser309GlnfsTer26) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.339 in 1,613,714 control chromosomes in the GnomAD database, including 95,899 homozygotes. Variant has been reported in ClinVar as Benign (★). Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: 𝑓 0.32 ( 8052 hom., cov: 0)
Exomes 𝑓: 0.34 ( 87847 hom. )

Consequence

PTCHD3
ENST00000642324.1 frameshift

Scores

Not classified

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.454

Publications

2 publications found
Variant links:
Genes affected
PTCHD3 (HGNC:24776): (patched domain containing 3 (gene/pseudogene)) Predicted to be located in sperm midpiece. Predicted to be active in membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP6
Variant 10-27413327-G-GC is Benign according to our data. Variant chr10-27413327-G-GC is described in ClinVar as Benign. ClinVar VariationId is 403352.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.353 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PTCHD3NM_001034842.5 linkc.923dupG p.Ser309GlnfsTer26 frameshift_variant Exon 1 of 4 NP_001030014.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PTCHD3ENST00000642324.1 linkc.923dupG p.Ser309GlnfsTer26 frameshift_variant Exon 1 of 4 ENSP00000495205.1

Frequencies

GnomAD3 genomes
AF:
0.320
AC:
48562
AN:
151816
Hom.:
8049
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.282
Gnomad AMI
AF:
0.427
Gnomad AMR
AF:
0.325
Gnomad ASJ
AF:
0.355
Gnomad EAS
AF:
0.163
Gnomad SAS
AF:
0.288
Gnomad FIN
AF:
0.294
Gnomad MID
AF:
0.296
Gnomad NFE
AF:
0.356
Gnomad OTH
AF:
0.344
GnomAD2 exomes
AF:
0.305
AC:
76766
AN:
251296
AF XY:
0.310
show subpopulations
Gnomad AFR exome
AF:
0.280
Gnomad AMR exome
AF:
0.239
Gnomad ASJ exome
AF:
0.347
Gnomad EAS exome
AF:
0.158
Gnomad FIN exome
AF:
0.294
Gnomad NFE exome
AF:
0.353
Gnomad OTH exome
AF:
0.315
GnomAD4 exome
AF:
0.341
AC:
497738
AN:
1461780
Hom.:
87847
Cov.:
61
AF XY:
0.340
AC XY:
246978
AN XY:
727194
show subpopulations
African (AFR)
AF:
0.278
AC:
9306
AN:
33478
American (AMR)
AF:
0.249
AC:
11120
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.344
AC:
8982
AN:
26136
East Asian (EAS)
AF:
0.130
AC:
5153
AN:
39700
South Asian (SAS)
AF:
0.298
AC:
25737
AN:
86254
European-Finnish (FIN)
AF:
0.300
AC:
16032
AN:
53414
Middle Eastern (MID)
AF:
0.324
AC:
1867
AN:
5768
European-Non Finnish (NFE)
AF:
0.359
AC:
399224
AN:
1111920
Other (OTH)
AF:
0.336
AC:
20317
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
21754
43508
65262
87016
108770
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
12542
25084
37626
50168
62710
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.320
AC:
48575
AN:
151934
Hom.:
8052
Cov.:
0
AF XY:
0.318
AC XY:
23602
AN XY:
74298
show subpopulations
African (AFR)
AF:
0.281
AC:
11645
AN:
41446
American (AMR)
AF:
0.325
AC:
4963
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
0.355
AC:
1231
AN:
3470
East Asian (EAS)
AF:
0.163
AC:
845
AN:
5186
South Asian (SAS)
AF:
0.288
AC:
1384
AN:
4798
European-Finnish (FIN)
AF:
0.294
AC:
3104
AN:
10570
Middle Eastern (MID)
AF:
0.305
AC:
89
AN:
292
European-Non Finnish (NFE)
AF:
0.356
AC:
24198
AN:
67886
Other (OTH)
AF:
0.344
AC:
727
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
1704
3409
5113
6818
8522
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
476
952
1428
1904
2380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.262
Hom.:
997
Bravo
AF:
0.315
Asia WGS
AF:
0.238
AC:
832
AN:
3478
EpiCase
AF:
0.360
EpiControl
AF:
0.363

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Benign:1
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency in 1000Genomes: 584/2178=26.81%

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.45
Mutation Taster
=133/67
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs75297921; hg19: chr10-27702256; COSMIC: COSV71256259; API